Draft guideline EMA on medicinal products containing genetically modified cells

The EMA published for public consultation a guideline on quality, non-clinical and clinical aspects of medicines containing genetically modified cells, including CAR-T cell and stem cell products. Share your thoughts by usi... read more

Qualification of cleanrooms and monitoring of aseptic processes

The Superior Health Council revised advice no 9453  “Qualification of cleanrooms and monitoring of aseptic processes in tissue banks, intermediate structures and production institutions”. More information on this topic:  FR... read more

Public consultation good clinical practice ATMP

The European Commission has launched an online targeted public consultation on the draft guidelines on good clinical practice for Advanced Medicinal Products addressed particularly to small and medium-sized enterprises (SMEs), academia, hospitals and patient organisations. The comme... read more

Compendium biobanks

The FAMPH has published a compendium to guide us through the new Biobank legislation and to answer our questions regarding the scope of this law, the implementation and notification procedures, consent of the donor, ethics committee, manager of the biobank, … and ma... read more

Master degree in transfusion medicine and advanced cell therapies

The aim of the Master’s programme is to provide a broad training in Transfusion medicine and advanced cell therapies so that students acquire the necessary skills to work in transfusion centres and also to carry out research in the related areas or develop technically qualified projects in the company sector. More info... read more

Extended abstract submission EATB congress 2018

The abstract submission of the European Association of Tissue Bank congress 2018 is extended until August 15. For more information visit the congress website www.eatb2018.org

 … Read more